CCM
CRL icon

Cadence Capital Management’s Charles River Laboratories CRL Stock Holding History

Cadence Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-7,120
Closed -$1.24M – 314
2020
Q2 		$1.24M Buy
7,120
+11
+0.2% +$1.76K 0.18% 180
2020
Q1 		$897K Sell
7,109
-183
-3% -$27.4K 0.15% 212
2019
Q4 		$1.11M Sell
7,292
-1,377
-16% -$191K 0.12% 241
2019
Q3 		$1.15M Sell
8,669
-196
-2% -$26.3K 0.16% 231
2019
Q2 		$1.26M Sell
8,865
-15
-0.2% -$2.04K 0.13% 234
2019
Q1 		$1.29M Sell
8,880
-2,724
-23% -$358K 0.12% 237
2018
Q4 		$1.31M Sell
11,604
-1,538
-12% -$193K 0.13% 224
2018
Q3 		$1.77M Buy
13,142
+873
+7% +$108K 0.1% 292
2018
Q2 		$1.38M Sell
12,269
-4,680
-28% -$506K 0.08% 323
2018
Q1 		$1.81M Sell
16,949
-276
-2% -$29.8K 0.12% 222
2017
Q4 		$1.89M Sell
17,225
-275
-2% -$29.9K 0.12% 207
2017
Q3 		$1.89M Hold
17,500
– – 0.12% 203
2017
Q2 		$1.77M Buy
17,500
+2,670
+18% +$246K 0.12% 198
2017
Q1 		$1.33M Buy
14,830
+6,853
+86% +$582K 0.09% 254
2016
Q4 		$608K Sell
7,977
-11,930
-60% -$906K 0.04% 463
2016
Q3 		$1.66M Sell
19,907
-11
-0.1% -$922 0.12% 208
2016
Q2 		$1.64M Buy
19,918
+2,810
+16% +$231K 0.12% 202
2016
Q1 		$1.3M Sell
17,108
-874
-5% -$64.7K 0.09% 252
2015
Q4 		$1.45M Sell
17,982
-224
-1% -$16.2K 0.1% 232
2015
Q3 		$1.16M Buy
+18,206
New +$1.31M 0.08% 260

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Cadence Capital Management's CRL Position: Q3 2020 in Review

Cadence Capital Management sold out of Charles River Laboratories (CRL) in Q3 2020, closing a stake of 7,120 shares — an estimated $1.24M sold.

Cadence Capital Management first reported a position in CRL in Q3 2015 and held it in 20 quarters. The position peaked at $1.89M in Q3 2017. 492 funds tracked by Wall St. Rank hold CRL as of Q3 2020.

  • Cadence Capital Management reported no remaining Charles River Laboratories position as of Q3 2020 after selling out during the quarter.
  • Cadence Capital Management sold 7,120 Charles River Laboratories shares in Q3 2020, an estimated $1.24M.
  • Cadence Capital Management first reported a position in Charles River Laboratories in Q3 2015 and held it in 20 quarters.
  • Cadence Capital Management's Charles River Laboratories position peaked at $1.89M in Q3 2017.
  • 492 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2020.

Based on Cadence Capital Management's 13F filing for Q3 2020, filed 16 Oct 2020.